ABCB News Alert Ameris Bancorp (ABCB) 25.96 11/13/2014 17:17

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ameris Bancorp (ABCB) 25.96 $ABCB

After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 4:35PM CST

AGTC: 23.30 (-0.91), BXE: 4.55 (-0.26), ROKA: 3.55 (-0.04), ALNY: 99.33 (-0.52), NCT: 4.79 (-0.06), SSRI: 4.79 (-0.15), ABCB: 25.96 (-0.52), OSIR: 13.30 (-0.20), XCO: 3.13 (-0.21), JDST: 26.67 (+2.42)

Has Ameris Bancorp Topped Out?
Profit Fan - at Seeking Alpha - Fri Oct 31, 1:49PM CDT

ABCB: 25.96 (-0.52)

Ameris Bancorp EPS in-line, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 7:46AM CDT

ABCB: 25.96 (-0.52)

Ameris Bancorp Reports Operating Net Income Of $12.0 Million, Or $0.44 Per Diluted Share, For Third Quarter 2014
PR Newswire - Wed Oct 22, 7:30AM CDT
AMERIS BANCORP (NASDAQ-GS: ABCB), today reported operating net income of $12.0 million, or $0.44 per diluted share, for the quarter ended September 30, 2014, compared to $6.6 million, or $0.27 per diluted share, for the quarter ended September 30, 2013. For the year to date period ending September 30, 2014, the Company reported operating net income of $30.5 million, or $1.17 per diluted share, compared to $17.3 million, or $0.71 per diluted share, for the same period in 2013. During the third quarter of 2014, the Company completed the conversion of Coastal Bankshares, Inc. ("Coastal" and recorded additional merger expenses totaling approximately $383,000, or $0.01 per share, on an after-tax basis. Including these charges, the Company reported net income for the third quarter of 2014 of $11.7 million, or $0.43 per share. Commenting on the Company's quarterly results, Edwin W. Hortman, Jr., the Company's President and Chief Executive Officer, said, "Our bankers turned in an outstanding quarter resulting in an 87% improvement in net earnings available to common shareholders compared to the same quarter in 2013. Additionally, our system conversion of Coastal was successful and we are working diligently to ensure that the cost savings we identified are realized and in place during the fourth quarter of 2014."
ABCB: 25.96 (-0.52)

As Market Slides, Several Growth Names Hang In There
at Investor's Business Daily - Thu Oct 16, 5:58PM CDT
A weak market has resulted in plenty of damage to leading growth stocks, but several institutional-quality names -- and some lesser-known ones -- have weathered the market storm quite well. Keurig Green Mountain (GMCR) is trading tightly near highs...
GMCR: 153.91 (+1.18), HDB: 52.06 (+0.26), TYL: 109.55 (-1.56), ABCB: 25.96 (-0.52), DPZ: 91.87 (+0.22), INFY: 67.96 (+0.81), MFRM: 68.62 (+1.13), ROST: 82.56 (-0.23)

Ameris Bancorp Up 10.8% Since SmarTrend Uptrend Call (ABCB)
Comtex SmarTrend(R) - Tue Aug 26, 9:26AM CDT
SmarTrend identified an Uptrend for Ameris Bancorp (NASDAQ:ABCB) on June 6th, 2014 at $21.67. In approximately 3 months, Ameris Bancorp has returned 10.78% as of today's recent price of $24.00.
ABCB: 25.96 (-0.52)

Ameris Bancorp Reports Operating Net Income Of $10.0 Million, Or $0.40 Per Diluted Share, For Second Quarter 2014
PR Newswire - Tue Jul 22, 3:01PM CDT
AMERIS BANCORP (NASDAQ-GS: ABCB), Moultrie, Georgia, today reported operating net income of $10.0 million, or $0.40 per diluted share, for the quarter ended June 30, 2014, compared to $6.2 million, or $0.26 per diluted share, for the quarter ended June 30, 2013. For the year to date period ending June 30, 2014, the Company reported operating net income of $18.1 million, or $0.71 per diluted share, compared to $11.1 million, or $0.46 per diluted share, for the same period in 2013. During the second quarter of 2014, the Company completed the acquisition of Coastal Bankshares, Inc. ("Coastal" and recorded approximately $1.90 million, or $0.075 per share, of after-tax merger related charges. Including these charges, the Company reported net income in the second quarter of 2014 of $8.1 million, or $0.32 per common share. Commenting on the Company's quarterly results, Edwin W. Hortman, Jr., the Company's President and Chief Executive Officer, said, "I am pleased with our operating results for the second quarter of 2014. Our operating return on average assets and return on tangible equity for the quarter improved from the prior period to 1.15% and 15.85%, respectively. Strong trends in loan growth, funded mostly with non-rate sensitive deposits, very solid mortgage results and over $1.1 million of SBA revenue were among the factors contributing to a successful quarter."
ABCB: 25.96 (-0.52)

Uptrend Call Working As Ameris Bancorp Stock Rises 23.2% (ABCB)
Comtex SmarTrend(R) - Tue Apr 01, 4:41PM CDT
SmarTrend identified an Uptrend for Ameris Bancorp (NASDAQ:ABCB) on November 14th, 2013 at $19.28. In approximately 5 months, Ameris Bancorp has returned 23.18% as of today's recent price of $23.75.
ABCB: 25.96 (-0.52)

Regional, Thrift Banks Are Seen Picking Up M&A Deals
at Investor's Business Daily - Mon Mar 31, 10:15AM CDT
M&A activity among regional banks is off to a "warmer" start this year vs. the prior two years as struggling banks look for ways to increase shareholder value, according to a new analyst report. Sterne Agee analyst Brett Rabatin notes that 28...
BHLB: 25.60 (-0.22), WAL: 26.52 (-0.43), ABCB: 25.96 (-0.52), FISI: 25.28 (+0.28), UBSI: 35.68 (-0.47), OZRK: 36.27 (-0.44), UMPQ: 17.64 (-0.20), HOMB: 32.55 (-0.24), IBKC: 68.98 (-1.00), HTH: 21.27 (+0.08), CHCO: 45.50 (-0.72), PB: 60.28 (-0.81), SCBT: 60.67 (+0.99)

Shares of ABCB Up 23.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Mar 25, 11:00AM CDT
SmarTrend identified an Uptrend for Ameris Bancorp (NASDAQ:ABCB) on November 14th, 2013 at $19.28. In approximately 4 months, Ameris Bancorp has returned 23.70% as of today's recent price of $23.85.
ABCB: 25.96 (-0.52)

Ameris Bancorp Announces Redemption Of Remaining TARP Preferred Stock
PR Newswire - Tue Mar 25, 9:32AM CDT
AMERIS BANCORP (NASDAQ-GS: ABCB), today announced the redemption, as of March 24, 2014, of the Company's remaining preferred stock originally issued under the U.S. Treasury's Troubled Asset Relief Program, totaling $28 million. In order to facilitate the redemption, the Company incurred no additional debt and issued no additional common equity, instead utilizing excess capital from its bank subsidiary, Ameris Bank. Commenting on the redemption, Edwin W. Hortman, Jr., President and CEO of the Company, said, "This final redemption of the TARP preferred stock brings to a close an important strategy for Ameris. As the economic crisis began to unfold, we vigorously increased our capital levels and were in a position to benefit from opportunities during the downturn. This additional, relatively inexpensive equity, played a part in our willingness to maintain a growth-oriented strategy through a volatile economic period. It is an important achievement for us to have been able to repay the entire $52 million of funds without issuing common stock or taking on additional borrowings."
ABCB: 25.96 (-0.52)

Ameris Bancorp Has Returned 23.4% Since SmarTrend Recommendation (ABCB)
Comtex SmarTrend(R) - Tue Mar 18, 9:35AM CDT
SmarTrend identified an Uptrend for Ameris Bancorp (NASDAQ:ABCB) on November 14th, 2013 at $19.28. In approximately 4 months, Ameris Bancorp has returned 23.44% as of today's recent price of $23.80.
ABCB: 25.96 (-0.52)

Ameris Bancorp (ABCB) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 8:21AM CDT
Ameris Bancorp (ABCB) Shares March Higher, Can It Continue?
ABCB: 25.96 (-0.52)

Ameris Bancorp (ABCB) in Focus: Stocks Moves 6.4% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 7:37AM CDT
Ameris Bancorp was a big mover last session, as the company saw its shares rise more than 6% on the day.
ANCX: 16.98 (-0.11), BKYF: 46.60 (-0.18), ABCB: 25.96 (-0.52), SYBT: 33.11 (-0.19)

Ameris Bancorp (ABCB) Enters Overbought Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 6:47AM CDT
Ameris Bancorp (ABCB) Enters Overbought Territory
ABCB: 25.96 (-0.52)

Ameris Bancorp Shares Up 13.5% Since SmarTrend's Buy Recommendation (ABCB)
Comtex SmarTrend(R) - Tue Mar 11, 9:22AM CDT
SmarTrend identified an Uptrend for Ameris Bancorp (NASDAQ:ABCB) on November 14th, 2013 at $19.28. In approximately 4 months, Ameris Bancorp has returned 13.49% as of today's recent price of $21.88.
ABCB: 25.96 (-0.52)

Ameris Bancorp Announces Acquisition of Coastal Bankshares, Inc.
PR Newswire - Tue Mar 11, 7:00AM CDT
Ameris Bancorp ("Ameris" , the parent company of Ameris Bank, announced today the signing of a definitive merger agreement under which Ameris will acquire Coastal Bankshares, Inc. ("Coastal" , the parent company of The Coastal Bank, Savannah, Georgia. As of December 31, 2013, Coastal reported assets of $433 million, loans of $295 million, and deposits of $364 million. Upon completion of the transaction, the combined company will have approximately $4.1 billion in assets, $2.8 billion in loans, $3.4 billion in deposits and a branch network of 74 banking locations across four states.
ABCB: 25.96 (-0.52)

WHOA.com Selects Gemini All-Flash Array from Nimbus Data for VDI Cloud Service
PR Newswire - Wed Jan 29, 7:13AM CST
Nimbus Data Systems, Inc., the leading provider of unified all-flash storage systems for enterprise and cloud infrastructure, today announced that WHOA.com has deployed the Gemini F620 all-flash array as the storage foundation for its new desktop-as-a-service (DaaS) offering.
ABCB: 25.96 (-0.52)

Ameris Bancorp Announces 2013 Financial Results
PR Newswire - Thu Jan 23, 3:00PM CST
AMERIS BANCORP (NASDAQ-GS: ABCB), Moultrie, Georgia, today reported unaudited operating net income of $23.6 million for the year ended December 31, 2013, compared to $14.4 million in 2012. Operating net income excludes $3.6 million of after-tax merger charges from the Company's net income for 2013. On an operating basis, net income available to common shareholders increased 101% to $21.9 million and $0.90 per share in 2013, compared to $10.9 million and $0.46 per share in 2012.
NBIX: 19.14 (-0.14), ABCB: 25.96 (-0.52)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading

Top 5 Most Recently Viewed Articles

U Power Limited Advances Electric Vehicle Solutions in Europe

Updated Category News Views 239

U Power Limited Expands Its European Reach U Power Limited (Nasdaq: UCAR) is making significant strides in the electric vehicle (EV) landscape. The company, known for its innovative battery-swapping technology, has announced an exciting joint venture that enhances their presence in the European market. This strategic move is expected to reshape how electric mobility is...

Continue Reading
UKG Stands Out as a Top Leader in Workforce Management Solutions

Updated Category News Views 163

UKG Secures Top Spot in Workforce Management UKG, a leading provider in HR, payroll, workforce management, and cultural solutions, has recently earned recognition for its exceptional contributions to the workforce management field. The company has been named a Leader in the NelsonHall New World Workforce Management 2024 evaluation, showcasing its strong performance across...

Continue Reading
Prominent Movers in Today's Market: Micron, Accenture Rise

Updated Category News Views 141

As the trading day unfolds, the US stock market is witnessing a shift, with several companies experiencing significant movements in their stock prices. Recent trends show that investors are closely monitoring the market after a minor disruption in gains. Micron's Robust Performance Micron Technology (NASDAQ: MU) has captured the spotlight today, with shares surging by an...

Continue Reading
Celebrate 1.5 Years of Obey Me! Nightbringer with Exciting Events

Updated Category News Views 85

Celebrating 1.5 Years of Obey Me! Nightbringer Obey Me! Nightbringer is reaching a significant milestone, celebrating its 1.5-year anniversary. This beloved mobile game from NTT Solmare has captured the hearts of players around the globe, and to acknowledge this momentous occasion, the developers are rolling out a variety of exciting events. Four Exciting Events for...

Continue Reading
Celebrating Innovation: 2026 sofi™ Awards Winners Unveiled

Updated Category News Views 219

Celebrating Culinary Excellence: The 2026 sofi™ Awards NEW YORK — The Specialty Food Association (SFA) revealed the much-anticipated results of the 2026 sofi™ Awards at the Winter FancyFaire event. This celebrated gathering brought together industry leaders, chefs, makers, and buyers to applaud the finest in specialty food and beverage innovation. A Night of...

Continue Reading